BioSpace News Archive

Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, announces that it has been engaged to develop and supply custom quality assessment products (QAPs™) to support the registration and sales of a new point-of-care instrument and its tests for viral respiratory pathogens.

Biomarck Pharmaceuticals, Ltd. , a biopharmaceutical company developing targeted anti-MARCKS technology for the treatment of ARDS [Acute Respiratory Distress Syndrome], cancer and other difficult to treat diseases, today announced new data from a Phase 2 study of its novel anti-MARCKS peptide BIO-11006 in non-small cell lung cancer (NSCLC), will be presented during the American Thoracic Society 2020 (ATS) virtual meeting

The AI cancer screening startup will use the funding to expand its suite of medical imaging AIs, and launch the Ezra COVID 360 offering.

AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that it has submitted applications for a new indication to the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) for RINVOQ™ (upadacitinib; 15 mg, once daily), a selective and reversible JAK inhibitor

First launched in 2013, the Translational Research Training in Addictions for Racial/Ethnic Minorities program at The City College of New York and Columbia University Medical Center set about increasing the number of scientists from underrepresented racial/ethnic minority groups conducting translational studies in addiction research.

A new peer-reviewed study in the journal SAGE Open Medicine detailing the health outcomes of vaccinated versus unvaccinated children concludes that unvaccinated children have better health outcomes than their vaccinated peers within the conditions examined and suggests that further study is necessary to understand the full spectrum of health effects associated with vaccination.

LuminUltra, the Canadian biotechnology leader and developer of the GeneCount qPCR system, and Florida-based Source Molecular, a leader in pathogen testing, today announced a strategic partnership designed to increase environmental testing for SARS-CoV-2 in North America

Scott J. Knoer, MS, PharmD, FASHP, was sworn in as the 13th Chief Executive Officer and Executive Vice President of the American Pharmacists Association, during a virtual ceremony witnessed by APhA members and staff.

Berkshire Sterile Manufacturing located in Lee, MA has secured $16.5 million in financing from Berkshire Bank and Lee Bank to expand its operations in Lee.

Study Demonstrates 5-Day Treatment Course of Remdesivir Resulted in Significantly Greater Clinical Improvement Versus Treatment with Standard of Care Alone -- -- Data Add to Body of Evidence from Prior Studies Demonstrating Benefit of Remdesivir in Hospitalized Patients with COVID-19 -- FOSTER CITY, Calif.--( BUSINESS WIRE )-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced topline results from the Phase 3 SIMPLE trial in hospitaliz